34.351.18% ( +0.40 )
Delay Closed: Nov 13, 15:00:00Valuation
Current ValuationThe current P/E ratio is 342.90, above the reasonable range, cheaper than 0.51% of the time in the past 3 years, and the industry ranks 33/41, the industry Median 32.91.
342.9xP/E
¥34.35Stock price
¥0.10Earnings per share
342.9xP/E
Stock price¥34.35Earnings per share¥0.10
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 42.70x
- Typical range
- -295.42x–251.88x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 32.91x
086172258344
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 32.91x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
301093SZHUALAN NPM | 264.57x | 119.62% | ¥10.34B |
301234SZWUZHOU MEDICAL | 423.49x | -- | ¥7.59B |
301122SZCAINA | 486.44x | 1,320.00% | ¥6.59B |
603976SHZhengchuan Pharmapack | 234.60x | -- | ¥4.83B |
301097SZTianyi Medical | 342.90x | -- | ¥2.80B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
